tiprankstipranks
Trending News
More News >
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Similar Stocks

Compare
88 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Design Therapeutics
$3.38
$188.45M
-14.21%
0 Buy
1 Hold
0 Sell
Hold
Neurogene
$10.77
$162.02M
-67.98%
7 Buy
0 Hold
0 Sell
Strong Buy
Annexon Biosciences
$1.43
$168.95M
-68.78%
7 Buy
0 Hold
0 Sell
Strong Buy
Foghorn Therapeutics
$3.47
$198.54M
-39.97%
3 Buy
0 Hold
0 Sell
Strong Buy
4D Molecular Therapeutics
$2.91
$143.54M
-88.50%
7 Buy
1 Hold
1 Sell
Moderate Buy
Terns Pharmaceuticals
$2.24
$209.51M
-50.66%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DSGN
Design Therapeutics
3.38
-0.36
-9.63%
NGNE
Neurogene
10.77
-20.81
-65.90%
ANNX
Annexon Biosciences
1.43
-3.01
-67.79%
FHTX
Foghorn Therapeutics
3.47
-2.06
-37.25%
FDMT
4D Molecular Therapeutics
2.91
-21.87
-88.26%
TERN
Terns Pharmaceuticals
2.24
-2.35
-51.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis